Intellectual Property Assets

TSG has built a solid intellectual property portfolio. The patents include the foundation patent in the field of antiviral peptides targeting Flaviviridae virus infections as well as cutting-edge developments in specific methods and compositions for targeting enveloped viruses in general. This strong patent portfolio will protect the core technology behind TSG and provide protection opportunities for at least 17 years (based on current projections, the earliest date for direct competition is 2035).